This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

D. Medical Announces Voluntary SEC Deregistration

GRANOT, Israel, March 20, 2013 (GLOBE NEWSWIRE) -- D. Medical Industries Ltd. (OTCBB:DMEDF) (TASE:DMED) (" D. Medical" or the " Company"), announced today that its Board of Directors approved the filing of a Form 15F with the Securities and Exchange Commission (" SEC") to voluntarily deregister its ordinary shares under the Securities Exchange Act of 1934 (the " Exchange Act"). The Company intends to file the Form 15F on or about March 29, 2013. The Company's reporting obligations under the Exchange Act will be suspended immediately upon the filing of Form 15F and will terminate 90 days thereafter if there are no objections from the SEC.  The Company reserves the right to delay or withdraw the filing for any reason prior to their effectiveness.

Following the deregistration, the Company's ordinary shares may continue to be quoted on the OTC Markets Group Inc. electronic quotation service (the "Pink Sheets") if market makers commit to make a market in the Company's shares.  However, the Company has not arranged for quotation on the Pink Sheets or listing or quotation on any other exchange or quotation medium within the U.S.  Thus, the Company can provide no assurance that trading in its ordinary shares will be quoted on the Pink Sheets or otherwise.  The Company's ordinary shares will continue to trade on the Tel Aviv Stock Exchange Ltd. (TASE:DMED).

In deciding to voluntarily deregister its ordinary shares, the Company's Board of Directors considered several factors, including the following:

  • low U.S. trading volume;
  • high public company costs in the U.S., including those associated with preparation and filing of the Company's periodic reports with the SEC;
  • significant management time spent on U.S. regulatory compliance; and
  • the potential impact of deregistration on Company shareholders resident in the U.S.
CONTACT: Company Contact:

         Orly Benizri Solomon
         Chief Executive Officer
         D. Medical Industries Ltd.
         T: +972-70-2508715
         orly@dmedicalindustries.com

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,996.19 +283.53 1.60%
S&P 500 2,084.31 +23.29 1.13%
NASDAQ 4,937.5940 +46.3750 0.95%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs